The Targeted Agent and Profiling Utilization Registry (TAPUR) study is ASCO’s first clinical trial. In this podcast, ASCO Chief Medical Officer Dr. Richard Schilsky discusses TAPUR and why it is important to patients and the medical community.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. Today’s highlights cover research that could potentially have the greatest impact to patient care for breast cancer, glioblastoma, neuroblastoma, and multiple myeloma.
Oncology professionals from around the world are in Chicago for the ASCO Annual Meeting. There, they will discuss the latest advances and newest thoughts in cancer research. These studies provide a glimpse into the exciting future of precision medicine.
Sumanta Pal, MD, discusses one study on aspirin and prostate cancer highlighted at the 2016 Genitourinary Cancers Symposium.
In this podcast, Erica L. Mayer, MD, MPH, reports on notable highlights from the San Antonio Breast Cancer Symposium.
Michael E. Williams, MD, ScM discusses highlights from the recent American Society of Hematology Annual Meeting. Listen in to hear what’s new in treatment for blood cancers.
Neal Meropol, MD, FASCO, discusses the various segments, or “phases,” that mark clinical trials.
Susan Cohn, MD, shares a personal story about the courage of parents who enrolled their child in a clinical trial for a drug that is now approved to treat neuroblastoma.
Edward S. Kim, MD, FACP, shares new approaches to molecular medicine that are helping doctors to better treat patients with cancer.
In this podcast, Leslie R. Schover, PhD, discusses the sexual concerns that often come with hormone therapy for prostate cancer.
